The authors compared the risk for subjective cognitive impairment (SCI) between carriers of the apolipoprotein E ε4 (APOE ε4) allele (cases) and APOE ε4 noncarriers (controls). SCI was assessed by a validated self-reported questionnaire. The authors used multivariable logistic regression analyses to compute odds ratios and 95% confidence intervals adjusted for age, sex, education, and marital status. Data were available on 114 participants (83 women; 47 APOE ε4 carriers; mean age, 69 years). The risk for SCI was significantly higher among cases than controls, particularly for those 70 years of age and older. These findings should be considered preliminary until confirmed by a prospective cohort study.

From the Mayo Clinic Scottsdale AZ

Zobrazit více v PubMed

Dubois B, Feldman HH, Jacova C. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010;9:1118–1127. PubMed

Sperling RA, Aisen PS, Beckett LA. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:280–292. PubMed PMC

Reisberg B, Gauthier S. Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. International Psychogeriatrics. 2008;20:1–16. PubMed

Reisberg B, Prichep L, Mosconi L. The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease. Alzheimers Dement. 2008;4:S98–S108. PubMed

Reisberg B, Shulman MB. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008" Subjective cognitive impairment as an antecedent of Alzheimer's dementia: policy import. Alzheimers Dement. 2009;5:154–156. PubMed PMC

Amariglio RE, Townsend MK, Grodstein F. Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc. 2011;59:1612–1617. PubMed PMC

Steinberg SI, Negash S, Sammel MD. Subjective memory complaints, cognitive performance, and psychological factors in healthy older adults. Am J Alzheimers Dis Other Demen. 2013;28:776–783. PubMed PMC

Reisberg B, Ferris SH, de Leon MJ. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136–1139. PubMed

Caselli RJ, Chen K, Locke DE. Subjective cognitive decline: self and informant comparisons. Alzheimers Dement. 2014;10:93–98. PubMed PMC

Visser PJ, Verhey F, Knol DL. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol. 2009;8:619–627. PubMed

Stewart R, Dufouil C, Godin O, et al. Neuroimaging correlates of subjective memory deficits in a community population. Neurology. 2008;70:1601–1607. PubMed

Perrotin A, Mormino EC, Madison CM. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Arch Neurol. 2012;69:223–229. PubMed PMC

Saykin AJ, Wishart HA, Rabin LA. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology. 2006;67:834–842. PubMed PMC

Corder EH, Saunders AM, Strittmatter WJ. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923. PubMed

Saunders AM, Strittmatter WJ, Schmechel D. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467–1472. PubMed

Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med. 1996;47:387–400. PubMed

Boyle PA, Buchman AS, Wilson RS. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons. Neuroepidemiology. 2010;34:43–49. PubMed PMC

Petersen RC, Smith GE, Waring SC. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308. PubMed

Petersen RC, Smith GE, Ivnik RJ. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273:1274–1278. PubMed

Petersen RC, Waring SC, Smith GE. Predictive value of APOE genotyping in incipient Alzheimer's disease. Ann N Y Acad Sci. 1996;802:58–69. PubMed

Blesa R, Adroer R, Santacruz P. High apolipoprotein E epsilon 4 allele frequency in age-related memory decline. Ann Neurol. 1996;39:548–551. PubMed

Laws SM, Clarnette RM, Taddei K. APOE-epsilon4 and APOE-491A polymorphisms in individuals with subjective memory loss. Mol Psychiatry. 2002;7:768–775. PubMed

Small GW, Chen ST, Komo S. Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele. Am J Psychiatry. 1999;156:1035–1038. PubMed

Harwood DG, Barker WW, Ownby RL. No association between subjective memory complaints and apolipoprotein E genotype in cognitively intact elderly. Int J Geriatr Psychiatry. 2004;19:1131–1139. PubMed

Dik MG, Jonker C, Comijs HC. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly. Neurology. 2001;57:2217–2222. PubMed

Caselli RJ, Dueck AC, Osborne D. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med. 2009;361:255–263. PubMed PMC

Gilewski MJ, Zelinski EM, Schaie KW. The Memory Functioning Questionnaire for assessment of memory complaints in adulthood and old age. Psychol Aging. 1990;5:482–490. PubMed

Zelinski EM, Gilewski MJ, Anthony-Bergstone CR. Memory Functioning Questionnaire: concurrent validity with memory performance and self-reported memory failures. Psychol Aging. 1990;5:388–399. PubMed

Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31:545–548. PubMed

Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. PubMed

Crum RM, Anthony JC, Bassett SS. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269:2386–2391. PubMed

Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. PubMed PMC

Pfeffer RI, Kurosaki TT, Harrah CH. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37:323–329. PubMed

Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–186. PubMed

Rey A. L'examen clinique en psychologie. Paris: Presses Universitaires de France; 1964.

Lezak MD. Neuropsychological assessment. 4th ed. Oxford ; New York: Oxford University Press; 2004.

Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol. 2005;62:1160–1163. PubMed

Wang X, Wang H, Li H. Frequency of the Apolipoprotein E epsilon4 Allele in a Memory Clinic Cohort in Beijing: A Naturalistic Descriptive Study. PLoS One. 2014;9:e99130. PubMed PMC